Intra-Cellular Therapies, Inc. Annual Operating Margin in % from 2012 to 2017

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Intra-Cellular Therapies, Inc. quarterly/annual Operating Margin history and growth rate from 2012 to 2017.
  • Intra-Cellular Therapies, Inc. Operating Margin for the quarter ending December 31, 2022 was -105 %, a 69.1% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Operating Margin for 2017 was -41.8K %, a 17% decline from 2016.
  • Intra-Cellular Therapies, Inc. annual Operating Margin for 2016 was -35.8K %, a 69.1% increase from 2015.
  • Intra-Cellular Therapies, Inc. annual Operating Margin for 2015 was -116K %, a 2058% decline from 2014.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2017 -41.8K -6.07K -17% Jan 1, 2017 Dec 31, 2017
2016 -35.8K +80.1K +69.1% Jan 1, 2016 Dec 31, 2016
2015 -116K -110K -2058% Jan 1, 2015 Dec 31, 2015
2014 -5.37K -4.41K -459% Jan 1, 2014 Dec 31, 2014
2013 -960 -434 -82.4% Jan 1, 2013 Dec 31, 2013
2012 -526 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.